Page last updated: 2024-08-24

3-iodobenzylguanidine and Impotence

3-iodobenzylguanidine has been researched along with Impotence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capoluongo, E; Defeudis, G; Fioriti, E; Manfrini, S; Minucci, A; Palermo, A; Pozzilli, P; Tuccinardi, D1
Berg, D; Postuma, RB1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Impotence

ArticleYear
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
    Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:5

    Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders

2019

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Impotence

ArticleYear
A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
    Hormones (Athens, Greece), 2018, Volume: 17, Issue:2

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Erectile Dysfunction; Genetic Testing; Humans; Male; Middle Aged; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Tomography, X-Ray Computed; Von Hippel-Lindau Tumor Suppressor Protein

2018